SG

Simerpreet Ghai

Active Director Director DIN 10592733
DIN 10592733 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Simerpreet Ghai

Data last updated:

Simerpreet Ghai is a Director at Monatt Biotech Private Limited (since 2025) and Director at Symatt Healthcare Private Limited (since 2024). The companies operate in Pharma.

DIN 10592733
Primary Designation Director
Industry Pharma
First Appointment 22 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Monatt Biotech Private Limited U47721PB2025PTC064003
Director26 Mar 20252025Active
Symatt Healthcare Private Limited U47721PB2024PTC061387
Director22 Apr 20242024Active

Board colleagues of Simerpreet Ghai

Directorship timeline

Open interactive timeline →
Monatt Biotech Private Limited
Symatt Healthcare Private Limited
Premium access

Shareholding and investment profile for Simerpreet Ghai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Simerpreet Ghai

Simerpreet Ghai currently holds 2 directorships: Monatt Biotech Private Limited (Director, since 26 Mar 2025); Symatt Healthcare Private Limited (Director, since 22 Apr 2024).

Simerpreet Ghai was first appointed on 22 Apr 2024 as Director at Symatt Healthcare Private Limited. The most recent appointment on record is 26 Mar 2025 at Monatt Biotech Private Limited.

The current boards of Simerpreet Ghai's companies include Manjit Singh (Monatt Biotech Private Limited), Surinder Singh (Monatt Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available